Accretion Pharmaceuticals Ltd.
192.00-8.0 (-4.00%)
25 Aug, 1:59 PM
Corporate Announcements and Regulatory Filings
Accretion Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
- The Exchange had sought clarification from Accretion Pharmaceuticals Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
- Accretion Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 15, 2026, titled Company Delivers Robust Performance in H2 FY26: Revenue up 18.24% YoY and EBITDA up 4.50% and Growth Led by Volume Expansion and an Improved Product Mix, along with Wider Customer Base and Geographic Reach
- Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter7 Apr 2026Accretion Pharmaceuticals Limited has informed regarding Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Quarter ended on 31st March, 2026.
Frequently Asked Questions
Where can I download the annual report of Accretion Pharmaceuticals Ltd.?
Annual reports of Accretion Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Accretion Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Accretion Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Accretion Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Accretion Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Accretion Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Accretion Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Accretion Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Accretion Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Accretion Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Accretion Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Accretion Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Accretion Pharmaceuticals Ltd. is INE0T8T01010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Accretion Pharmaceuticals Ltd. listed?
Accretion Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is ACCPL and the BSE code is -.
Where can I find the shareholding pattern of Accretion Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Accretion Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Accretion Pharmaceuticals Ltd. on Sharpely?
Share price data for Accretion Pharmaceuticals Ltd. is updated as of 25 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.